Scientists report that they are trying to grow live human hearts in the laboratory. Dr. Doris Taylor of the University of Minnesota presented her team’s latest work at the annual meeting of the American College of Cardiology over the weekend.
A team of scientists from Thessaloniki, Greece, have shown that chemotherapy followed by adult stem cell transplant can stop progression of aggressive multiple sclerosis (MS).
The short answer is yes. But the real question is what they support doing with cloned human embryos.
The Oklahoma House has passed a bill that would prohibit human embryo destruction for experiments, by a vote of 86 votes in favor and 8 votes opposed. Contrary to what some news reports claim, the bill (HB 1442) sponsored by Rep. George Faught does not directly address embryonic stem cell research.
Results of a long-term study released Wednesday show that adult stem cells from a patient’s own fat tissue are safe for breast reconstruction for former breast cancer patients.
The embryonic stem cell and cloning company, Advanced Cell Technology (ACT), has been granted a patent for what it calls its “single-blastomere technique” for generating human embryonic stem cell lines.
Canadian scientists have produced the first induced pluripotent stem (iPS) cells from a horse. The cells show all the typical characteristics of pluripotent stem cells, including the formation of tumors in immuno-compromised mice.
Two recent stories are exciting about the possibility of treating young children, even in the womb, with adult stem cells. One study shows that cardiac adult stem cells can be isolated from young children with heart problems, even as young as one day old.